AGTC

AGTC (now operating as Beacon Therapeutics) is a clinical-stage biotechnology company focused on developing gene therapies for ocular diseases. The company uses adeno-associated virus (AAV) gene therapy technology to treat rare and prevalent retinal conditions including X-linked retinitis pigmentosa, dry age-related macular degeneration, and cone rod dystrophy. UpGuard continuously monitors the security posture of AGTC using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

AGTC Security Rating

X
---
/ 950
AGTC's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for AGTC.

Company info

AGTC
Company
AGTC
Employees
Location
Alachua, FL, United States.
CEO
Last updated
Last updated
Industries
Last updated today

AGTC Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of AGTC's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

AGTC Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to AGTC.

Security reports related to AGTC

Compare AGTC's security performance with other companies in their industry.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating